Genetic evidence of functional ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Assaf, Amal ^a,b   van Hoang, Tong ^a   Faik, Imad ^a   Aebischer, Toni ^c   Kremsner, Peter G ^a   Kun, Jürgen F J ^a   Velavan, T P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLIN; FICOLIN 2; GENOMIC DNA; UNCLASSIFIED DRUG; LECTIN; PRIMER DNA;

ADULT; ARAB; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; EXON; FCN2 GENE; FEMALE; GENE; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN LEISHMANIASIS; SYRIAN ARAB REPUBLIC; GENETIC PREDISPOSITION; GENETICS; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LECTINS; LEISHMANIASIS, CUTANEOUS;

EID: 84858769986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034113     Document Type: Article

References (42)

1. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. Lancet 366: 1561-1577.
2. Rivas L, Moreno J, Canavate C, Alvar J, (2004) Virulence and disease in leishmaniasis: What is relevant for the patient? Trends in Parasitology 20: 297-301.
3. Alexander J, Bryson K, (2005) T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunology Letters 99: 17-23.
4. Blackwell JM, (1996) Genetic susceptibility to leishmanial infections: Studies in mice and man. Parasitology 112: S67-S74.
5. Sacks D, Sher A, (2002) Evasion of innate immunity by parasitic protozoa. Nature Immunology 3: 1041-1047.
6. Sakthianandeswaren A, Foote SJ, Handman E, (2009) The role of host genetics in leishmaniasis. Trends in Parasitology 25: 383-391.
7. Lipoldova M, Demant P, (2006) Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nature Reviews Genetics 7: 294-305.
8. Cedzynski M, Nuytinck L, Atkinson APM, St Swierzko A, Zeman K, et al. (2007) Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clinical and Experimental Immunology 150: 99-104.
9. Hummelshoj T, Thielens NM, Madsen HO, Arlaud GJ, Sim RB, et al. (2007) Molecular organization of human Ficolin-2. Molecular Immunology 44: 401-411.
10. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, et al. (2005) Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Human Molecular Genetics 14: 1651-1658.
11. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC, (2004) L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 279: 47513-47519 10.1074/jbc.M407161200 [doi];M407161200 [pii].
12. Ambrosio AR, De Messias-Reason IJ, (2005) Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism. Parasite Immunol 27: 333-340 PIM782 [pii];10.1111/j.1365-3024.2005.00782.x [doi].
13. Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, et al. (2007) The impact of FCN2 polymorphisms and haplotypes on the ficolin-2 serum levels. Scandinavian Journal of Immunology 65: 383-392.
14. Atkinson APM, Cedzynski M, Szemraj J, Swierzko AS, Bar-Romaniszyn L, et al. (2004) L-ficolin in children with recurrent respiratory infections. Clinical and Experimental Immunology 138: 517-520.
15. Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, et al. (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. Journal of the American Society of Nephrology 17: 1724-1734.
16. Messias-Reason IJ, Schafranski MD, Kremsner PG, Kun JFJ, (2009) Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clinical and Experimental Immunology 157: 395-399.
17. de Messias-Reason I, Kremsner PG, Kun JF, (2009) Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis 199: 801-804.
18. Faik I, Oyedeji SI, Idris Z, de Messias-Reason IJ, Lell B, et al. (2011) Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Hum Immunol 72: 74-79 S0198-8859(10)00517-3 [pii];10.1016/j.humimm.2010.10.003 [doi].
19. Hoang TV, Toan NL, Song LH, Ouf EA, Bock CT, et al. (2011) Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS One 6: e28113 10.1371/journal.pone.0028113 [doi];PONE-D-11-14849 [pii].
20. Al Nahhas SA, (2009) Serodiagnosis of cutaneous leishmaniasis in the Syrian Arab Republic. Saudi Medical Journal 30: 382-386.
21. Jalouk L, Al Ahmed M, Gradoni L, Maroli M, (2007) Insecticide-treated bednets to prevent anthroponotic cutaneous leishmaniasis in Aleppo Governorate, Syria: results from two trials. Transactions of the Royal Society of Tropical Medicine and Hygiene 101: 360-367.
22. Tayeh A, Jalouk L, Cairncross S, (1997) Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Transactions of the Royal Society of Tropical Medicine and Hygiene 91: 657-659.
23. Gangneux JP, Sulahian A, Honore S, Meneceur P, Derouin F, et al. (2000) Evidence for determining parasitic factors in addition to host genetics and immune status in the outcome of murine Leishmania infantum visceral leishmaniasis. Parasite Immunology 22: 515-519.
24. Kamali-Sarvestani E, Rasouli M, Mortazavi H, Gharesi-Fard B, (2006) Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine 35: 159-165.
25. Bucheton B, Abel L, El Safi S, Kheir MM, Pavek S, et al. (2003) A major susceptibility locus on chromosome 22q12 plays a critical role in the control of Kala-azar. American Journal of Human Genetics 73: 1052-1060.
26. Jamieson SE, Miller EN, Peacock CS, Fakiola M, Wilson ME, et al. (2007) Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes and Immunity 8: 84-90.
27. Jeronimo SMB, Duggal P, Ettinger NA, Nascimento ET, Monteiro GR, et al. (2007) Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: A genomewide scan. Journal of Infectious Diseases 196: 1261-1269.
28. Miller EN, Fadl M, Mohamed HS, Elzein A, Jamieson SE, et al. (2007) Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan. Plos Genetics 3: 679-688.
29. Lacroix M, Dumestre-Perard C, Houen G, Arlaud G, Thielens N, (2008) Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play an essential role in interaction with the MASPs and the collectin co-receptor calreticulin. Molecular Immunology 45: 4134.
30. Ogden CA, deCathehneau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. Journal of Experimental Medicine 194: 781-795.
31. Santos IKFD, Costa CHN, Krieger H, Feitosa MF, Zurakowski D, et al. (2001) Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infection and Immunity 69: 5212-5215.
32. Alonso DP, Ferreira AFB, Ribolla PEM, Santos IKFD, Cruz MDSP, et al. (2007) Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications. Journal of Infectious Diseases 195: 1212-1217.
33. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A, (1994) Dual Role of Mannan-Binding Protein in Infections- Another Case of Heterosis. European Journal of Immunogenetics 21: 125-131.
34. Hellemann D, Larsson A, Madsen HO, Bonde J, Jarlov JO, et al. (2007) Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Human Molecular Genetics 16: 3071-3080.
35. Cestari ID, Krarup A, Sim RB, Inal JM, Ramirez MI, (2009) Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Molecular Immunology 47: 426-437.
36. Faik I, Oyedeji SI, Idris Z, Messias-Reason IJ, Lell B, et al. (2011) Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Human Immunology 72: 74-79.
37. Hummelshoj T, Munthe-Fog L, Madsen HO, Garred P, (2008) Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Molecular Immunology 45: 2508-2520.
38. Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM, (2008) Marring Leishmaniasis: The Stigmatization and the Impact of Cutaneous Leishmaniasis in Pakistan and Afghanistan. Plos Neglected Tropical Diseases 2.
39. Reithinger R, Aadil K, Kolaczinski J, Mohsen M, Hami S, (2005) Social impact of leishmaniasis, Afghanistan. Emerging Infectious Diseases 11: 634-636.
40. Cotterill JA, Cunliffe WJ, (1997) Suicide in dermatological patients. British Journal of Dermatology 137: 246-250.
41. Gupta MA, Gupta AK, (1998) Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. British Journal of Dermatology 139: 846-850.
42. Yanik M, Gurel MS, Simsek Z, Kati M, (2004) The psychological impact of cutaneous leishmaniasis. Clinical and Experimental Dermatology 29: 464-467.